{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "456482b2-214e-4d65-9fa8-9350ec644a09",
   "metadata": {},
   "source": [
    "# Vaccine"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "39f4091b-5b9e-4416-b043-1647a5062090",
   "metadata": {
    "tags": [
     "hide-input"
    ]
   },
   "outputs": [
    {
     "data": {
      "text/markdown": [
       "There are 19 documents with topic or summary including 'Vaccine'. Below is a list of these topics."
      ],
      "text/plain": [
       "<IPython.core.display.Markdown object>"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import pandas as pd\n",
    "from IPython.display import Markdown as md\n",
    "pd.set_option('display.max_rows', 200, 'display.max_colwidth', None)\n",
    "df=pd.read_csv(\"../suppfiles/lstcurrent.csv\")\n",
    "\n",
    "df['Issue Date0']= pd.to_datetime(df['Issue Date0'])\n",
    "lst2=df.drop(['Unnamed: 0','Issue Date'], axis=1).set_index(['Summary','Topic','FDA Organization']).filter(regex='Vaccine|Vaccines',axis=0).filter(regex='^((?!COVID).)*$',axis=0).reset_index()\n",
    "\n",
    "md(\"There are \"+str(len(lst2))+\" documents with topic or summary including 'Vaccine'. Below is a list of these topics.\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "ec419bc0-4309-4e96-ba63-d15a0412bd73",
   "metadata": {
    "tags": [
     "hide-input"
    ]
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th>Summary</th>\n",
       "      <th>Topic</th>\n",
       "      <th>Guidance Status</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Issue Date0</th>\n",
       "      <th>FDA Organization</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>2019-12-20</th>\n",
       "      <th>(CBER)</th>\n",
       "      <td>Submitting Study Datasets for Vaccines to the Office of Vaccines Research and Review:  Guidance for Industry; Technical Specifications Document</td>\n",
       "      <td>Electronic Submissions, Administrative / Procedural</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2016-03-01</th>\n",
       "      <th>(CBER)</th>\n",
       "      <td>Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal Microbiota for Transplantation to Treat Clostridium difficile Infection Not Responsive to Standard Therapies: Draft Guidance for Industry</td>\n",
       "      <td>Vaccines</td>\n",
       "      <td>Draft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2015-08-18</th>\n",
       "      <th>(CBER)</th>\n",
       "      <td>Providing Submissions in Electronic Format â€” Postmarketing Safety Reports for Vaccines:  Guidance for Industry</td>\n",
       "      <td>Postmarket, Electronic Submissions, Safety - Issues, Errors, and Problems, Vaccines</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2015-03-01</th>\n",
       "      <th>(CBER)</th>\n",
       "      <td>Determining the Need for and Content of Environmental Assessments for Gene Therapies, Vectored Vaccines, and Related Recombinant Viral or Microbial Products:  Guidance for Industry</td>\n",
       "      <td>Gene Therapy</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-01</th>\n",
       "      <th>(CBER)</th>\n",
       "      <td>Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal Microbiota for Transplantation to Treat Clostridium difficile Infection Not Responsive to Standard Therapies:  Guidance for Industry</td>\n",
       "      <td>Vaccines</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2011-12-01</th>\n",
       "      <th>(CBER)</th>\n",
       "      <td>General Principles for the Development of Vaccines to Protect Against Global Infectious Diseases:  Guidance for Industry</td>\n",
       "      <td>Vaccines</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2011-10-01</th>\n",
       "      <th>(CBER)</th>\n",
       "      <td>Clinical Considerations for Therapeutic Cancer Vaccines:  Guidance for Industry</td>\n",
       "      <td>Cellular &amp; Gene Therapy, Gene Therapy, Vaccines, Good Clinical Practice (GCP)</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2010-02-01</th>\n",
       "      <th>(CBER)</th>\n",
       "      <td>Characterization and Qualification of Cell Substrates and Other Biological Materials Used in the Production of Viral Vaccines for Infectious Disease Indications:  Guidance for Industry</td>\n",
       "      <td>Vaccines</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2007-11-01</th>\n",
       "      <th>(CBER)</th>\n",
       "      <td>Considerations for Plasmid DNA Vaccines for Infectious Disease Indications:  Guidance for Industry</td>\n",
       "      <td>Vaccines</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2007-09-27</th>\n",
       "      <th>(CBER)</th>\n",
       "      <td>Toxicity Grading Scale for Healthy Adult and Adolescent Volunteers Enrolled in Preventive Vaccine Clinical Trials:  Guidance for Industry</td>\n",
       "      <td>Vaccines</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th rowspan=\"2\" valign=\"top\">2007-05-31</th>\n",
       "      <th>(CBER)</th>\n",
       "      <td>Clinical Data Needed to Support the Licensure of Pandemic Influenza Vaccines:  Guidance for Industry</td>\n",
       "      <td>Vaccines</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>(CBER)</th>\n",
       "      <td>Clinical Data Needed to Support the Licensure of Seasonal Inactivated Influenza Vaccines:  Guidance for Industry</td>\n",
       "      <td>Vaccines</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2006-02-01</th>\n",
       "      <th>(CBER)</th>\n",
       "      <td>Considerations for Developmental Toxicity Studies for Preventive and Therapeutic Vaccines for Infectious Disease Indications:  Guidance for Industry</td>\n",
       "      <td>Vaccines</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2004-10-01</th>\n",
       "      <th>(CBER)</th>\n",
       "      <td>FDA Review of Vaccine Labeling Requirements for Warnings, Use Instructions, and Precautionary Information:  Guidance for Industry</td>\n",
       "      <td>Vaccines</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2002-12-30</th>\n",
       "      <th>(CBER)</th>\n",
       "      <td>Recommendations for Deferral of Donors and Quarantine and Retrieval of Blood and Blood Products in Recent Recipients of Smallpox Vaccine (Vaccinia Virus) and Certain Contacts of Smallpox Vaccine Recipients:  Guidance for Industry</td>\n",
       "      <td>Blood Products</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2001-03-12</th>\n",
       "      <th>(CDER) (CBER)</th>\n",
       "      <td>Postmarketing Safety Reporting for Human Drug and Biological Products Including Vaccines: Draft Guidance for Industry</td>\n",
       "      <td>Safety - Issues, Errors, and Problems, Vaccines</td>\n",
       "      <td>Draft</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1999-01-05</th>\n",
       "      <th>(CBER)</th>\n",
       "      <td>Content and Format of Chemistry, Manufacturing and Controls Information and Establishment Description Information for a Vaccine or Related Product:  Guidance for Industry</td>\n",
       "      <td>Vaccines</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1998-09-09</th>\n",
       "      <th>(CBER)</th>\n",
       "      <td>How to Complete the Vaccine Adverse Event Reporting System Form (VAERS-1):  Guidance for Industry</td>\n",
       "      <td>Vaccines</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1997-04-10</th>\n",
       "      <th>(CBER)</th>\n",
       "      <td>Guidance for Industry for the Evaluation of Combination Vaccines for Preventable Diseases: Production, Testing and Clinical Studies:  Guidance for Industry</td>\n",
       "      <td>Vaccines</td>\n",
       "      <td>Final</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                                                                                                                                                                                                            Summary  \\\n",
       "Issue Date0 FDA Organization                                                                                                                                                                                                                                          \n",
       "2019-12-20  (CBER)                                                                                                  Submitting Study Datasets for Vaccines to the Office of Vaccines Research and Review:  Guidance for Industry; Technical Specifications Document   \n",
       "2016-03-01  (CBER)                    Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal Microbiota for Transplantation to Treat Clostridium difficile Infection Not Responsive to Standard Therapies: Draft Guidance for Industry   \n",
       "2015-08-18  (CBER)                                                                                                                                   Providing Submissions in Electronic Format â€” Postmarketing Safety Reports for Vaccines:  Guidance for Industry   \n",
       "2015-03-01  (CBER)                                                             Determining the Need for and Content of Environmental Assessments for Gene Therapies, Vectored Vaccines, and Related Recombinant Viral or Microbial Products:  Guidance for Industry   \n",
       "2013-07-01  (CBER)                         Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal Microbiota for Transplantation to Treat Clostridium difficile Infection Not Responsive to Standard Therapies:  Guidance for Industry   \n",
       "2011-12-01  (CBER)                                                                                                                         General Principles for the Development of Vaccines to Protect Against Global Infectious Diseases:  Guidance for Industry   \n",
       "2011-10-01  (CBER)                                                                                                                                                                  Clinical Considerations for Therapeutic Cancer Vaccines:  Guidance for Industry   \n",
       "2010-02-01  (CBER)                                                         Characterization and Qualification of Cell Substrates and Other Biological Materials Used in the Production of Viral Vaccines for Infectious Disease Indications:  Guidance for Industry   \n",
       "2007-11-01  (CBER)                                                                                                                                               Considerations for Plasmid DNA Vaccines for Infectious Disease Indications:  Guidance for Industry   \n",
       "2007-09-27  (CBER)                                                                                                        Toxicity Grading Scale for Healthy Adult and Adolescent Volunteers Enrolled in Preventive Vaccine Clinical Trials:  Guidance for Industry   \n",
       "2007-05-31  (CBER)                                                                                                                                             Clinical Data Needed to Support the Licensure of Pandemic Influenza Vaccines:  Guidance for Industry   \n",
       "            (CBER)                                                                                                                                 Clinical Data Needed to Support the Licensure of Seasonal Inactivated Influenza Vaccines:  Guidance for Industry   \n",
       "2006-02-01  (CBER)                                                                                             Considerations for Developmental Toxicity Studies for Preventive and Therapeutic Vaccines for Infectious Disease Indications:  Guidance for Industry   \n",
       "2004-10-01  (CBER)                                                                                                                FDA Review of Vaccine Labeling Requirements for Warnings, Use Instructions, and Precautionary Information:  Guidance for Industry   \n",
       "2002-12-30  (CBER)            Recommendations for Deferral of Donors and Quarantine and Retrieval of Blood and Blood Products in Recent Recipients of Smallpox Vaccine (Vaccinia Virus) and Certain Contacts of Smallpox Vaccine Recipients:  Guidance for Industry   \n",
       "2001-03-12  (CDER) (CBER)                                                                                                                     Postmarketing Safety Reporting for Human Drug and Biological Products Including Vaccines: Draft Guidance for Industry   \n",
       "1999-01-05  (CBER)                                                                       Content and Format of Chemistry, Manufacturing and Controls Information and Establishment Description Information for a Vaccine or Related Product:  Guidance for Industry   \n",
       "1998-09-09  (CBER)                                                                                                                                                How to Complete the Vaccine Adverse Event Reporting System Form (VAERS-1):  Guidance for Industry   \n",
       "1997-04-10  (CBER)                                                                                      Guidance for Industry for the Evaluation of Combination Vaccines for Preventable Diseases: Production, Testing and Clinical Studies:  Guidance for Industry   \n",
       "\n",
       "                                                                                                            Topic  \\\n",
       "Issue Date0 FDA Organization                                                                                        \n",
       "2019-12-20  (CBER)                                            Electronic Submissions, Administrative / Procedural   \n",
       "2016-03-01  (CBER)                                                                                       Vaccines   \n",
       "2015-08-18  (CBER)            Postmarket, Electronic Submissions, Safety - Issues, Errors, and Problems, Vaccines   \n",
       "2015-03-01  (CBER)                                                                                   Gene Therapy   \n",
       "2013-07-01  (CBER)                                                                                       Vaccines   \n",
       "2011-12-01  (CBER)                                                                                       Vaccines   \n",
       "2011-10-01  (CBER)                  Cellular & Gene Therapy, Gene Therapy, Vaccines, Good Clinical Practice (GCP)   \n",
       "2010-02-01  (CBER)                                                                                       Vaccines   \n",
       "2007-11-01  (CBER)                                                                                       Vaccines   \n",
       "2007-09-27  (CBER)                                                                                       Vaccines   \n",
       "2007-05-31  (CBER)                                                                                       Vaccines   \n",
       "            (CBER)                                                                                       Vaccines   \n",
       "2006-02-01  (CBER)                                                                                       Vaccines   \n",
       "2004-10-01  (CBER)                                                                                       Vaccines   \n",
       "2002-12-30  (CBER)                                                                                 Blood Products   \n",
       "2001-03-12  (CDER) (CBER)                                         Safety - Issues, Errors, and Problems, Vaccines   \n",
       "1999-01-05  (CBER)                                                                                       Vaccines   \n",
       "1998-09-09  (CBER)                                                                                       Vaccines   \n",
       "1997-04-10  (CBER)                                                                                       Vaccines   \n",
       "\n",
       "                             Guidance Status  \n",
       "Issue Date0 FDA Organization                  \n",
       "2019-12-20  (CBER)                     Final  \n",
       "2016-03-01  (CBER)                     Draft  \n",
       "2015-08-18  (CBER)                     Final  \n",
       "2015-03-01  (CBER)                     Final  \n",
       "2013-07-01  (CBER)                     Final  \n",
       "2011-12-01  (CBER)                     Final  \n",
       "2011-10-01  (CBER)                     Final  \n",
       "2010-02-01  (CBER)                     Final  \n",
       "2007-11-01  (CBER)                     Final  \n",
       "2007-09-27  (CBER)                     Final  \n",
       "2007-05-31  (CBER)                     Final  \n",
       "            (CBER)                     Final  \n",
       "2006-02-01  (CBER)                     Final  \n",
       "2004-10-01  (CBER)                     Final  \n",
       "2002-12-30  (CBER)                     Final  \n",
       "2001-03-12  (CDER) (CBER)              Draft  \n",
       "1999-01-05  (CBER)                     Final  \n",
       "1998-09-09  (CBER)                     Final  \n",
       "1997-04-10  (CBER)                     Final  "
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "lst2.set_index(['Issue Date0','FDA Organization']).sort_values(['Issue Date0','FDA Organization'],ascending=False).drop(['Open for Comment','Docket Number'], axis=1)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "P3_nbenv",
   "language": "python",
   "name": "nbenv"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.12"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
